Analyst Consensus ?
ConsensusBuy38 ratings
Bullish2771.1%
Neutral1128.9%
Bearish00.0%
FN2 Earnings Intelligence
Elevance Health Inc. analyst ratings
Elevance Health Inc. (ELV) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$421.09Current
$320Low
$479.96Average
$625High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Buy | Buy | Maintain | Oct 23, 2026 |
| UBS | Buy | Buy | Maintain | Oct 22, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Oct 22, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Oct 22, 2026 |
| Guggenheim | Buy | Buy | Maintain | Oct 22, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 22, 2026 |
| Baird | Neutral | Neutral | Maintain | Oct 22, 2026 |
| Leerink Partners | Market Perform | Market Perform | Maintain | Jul 17, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jul 17, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 16, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 14, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jul 7, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jun 8, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jun 8, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jun 4, 2026 |
| Deutsche Bank | Buy | Hold | Upgrade | May 20, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Apr 23, 2026 |
| Jefferies | Buy | Buy | Maintain | Apr 20, 2026 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jan 8, 2026 |
| Argus Research | Hold | Buy | Downgrade | Jul 21, 2025 |
| Stephens & Co. | Overweight | Overweight | Maintain | Sep 5, 2024 |
| Loop Capital | Buy | Buy | Maintain | Apr 21, 2023 |
| SVB Leerink | Outperform | Outperform | Maintain | Jan 26, 2023 |
| BMO Capital | Outperform | Outperform | Maintain | Apr 25, 2022 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 21, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Apr 21, 2022 |
| Cowen & Co. | Outperform | Outperform | Maintain | Apr 14, 2021 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | May 21, 2020 |
| CFRA | Buy | Hold | Upgrade | Apr 29, 2020 |
| Bank of America | Neutral | Buy | Downgrade | Dec 6, 2019 |
| Citigroup | Neutral | Neutral | Maintain | Nov 6, 2018 |
| PiperJaffray | Overweight | Neutral | Upgrade | Jan 3, 2018 |
| Leerink Swann | Outperform | Outperform | Maintain | Nov 7, 2017 |
| Stifel Nicolaus | Hold | Buy | Downgrade | Jan 4, 2017 |
| FBR Capital | Market Perform | Market Perform | Maintain | Jan 28, 2016 |
| Sterne Agee CRT | Buy | Neutral | Upgrade | Jul 27, 2015 |
| Susquehanna | Positive | Positive | Maintain | May 22, 2015 |
| Oppenheimer | Outperform | Outperform | Maintain | May 1, 2015 |
Named analyst price targets
Upside is calculated against the persisted current price $421.09. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Piper Sandler | Analyst unavailable | $520 | $442.85 | +23.5% | Oct 23, 2026 |
| Mizuho Securities | Ann Hynes | $490 | $445.28 | +16.4% | Oct 23, 2026 |
| Goldman Sachs | Analyst unavailable | $451 | $445.28 | +7.1% | Oct 23, 2026 |
| UBS | Analyst unavailable | $523 | $439.1 | +24.2% | Oct 22, 2026 |
| RBC Capital | Analyst unavailable | $455 | $441.21 | +8.1% | Oct 22, 2026 |
| Guggenheim | Jason Cassorla | $485 | $434.13 | +15.2% | Oct 22, 2026 |
| Robert W. Baird | Analyst unavailable | $406 | $434.13 | -3.6% | Oct 22, 2026 |
| Barclays | Analyst unavailable | $472 | $434.13 | +12.1% | Oct 22, 2026 |
| Guggenheim | Jason Cassorla | $460 | $412.7 | +9.2% | Oct 12, 2026 |
| Barclays | Analyst unavailable | $469 | $400.09 | +11.4% | Oct 7, 2026 |
| Leerink Partners | Analyst unavailable | $395 | $369.28 | -6.2% | Jul 17, 2026 |
| Bernstein | Analyst unavailable | $488 | $372.85 | +15.9% | Jul 16, 2026 |
| New Street | Analyst unavailable | $482 | $377.63 | +14.5% | Jul 16, 2026 |
| RBC Capital | Analyst unavailable | $424 | $390.33 | +0.7% | Jul 16, 2026 |
| Goldman Sachs | Analyst unavailable | $395 | $390.33 | -6.2% | Jul 16, 2026 |
| Robert W. Baird | Analyst unavailable | $393 | $390.33 | -6.7% | Jul 16, 2026 |
| Guggenheim | Analyst unavailable | $455 | $390.33 | +8.1% | Jul 16, 2026 |
| Wells Fargo | Stephen Baxter | $473 | $390.33 | +12.3% | Jul 16, 2026 |
| Barclays | Analyst unavailable | $457 | $390.33 | +8.5% | Jul 16, 2026 |
| Truist Financial | Analyst unavailable | $475 | $425.17 | +12.8% | Jul 14, 2026 |
| Wells Fargo | Analyst unavailable | $492 | $416.23 | +16.8% | Jul 13, 2026 |
| RBC Capital | Ben Hendrix | $439 | $425.9 | +4.3% | Jul 9, 2026 |
| Raymond James | Sarah James | $450 | $408.17 | +6.9% | Jul 7, 2026 |
| Bernstein | Analyst unavailable | $482 | $416.19 | +14.5% | Jul 2, 2026 |
| Mizuho Securities | Analyst unavailable | $465 | $415.53 | +10.4% | Jun 8, 2026 |
| Morgan Stanley | Analyst unavailable | $404 | $391.27 | -4.1% | Jun 4, 2026 |
| Truist Financial | David MacDonald | $450 | $393.19 | +6.9% | Jun 1, 2026 |
| Barclays | Andrew Mok | $480 | $386.87 | +14.0% | May 26, 2026 |
| UBS | Analyst unavailable | $460 | $389.82 | +9.2% | May 22, 2026 |
| Mizuho Securities | Analyst unavailable | $435 | $402.27 | +3.3% | May 20, 2026 |
| Deutsche Bank | Analyst unavailable | $498 | $402.27 | +18.3% | May 20, 2026 |
| Guggenheim | Analyst unavailable | $399 | $346.29 | -5.2% | Apr 24, 2026 |
| Barclays | Analyst unavailable | $408 | $346.29 | -3.1% | Apr 24, 2026 |
| Leerink Partners | Analyst unavailable | $364 | $346.21 | -13.6% | Apr 23, 2026 |
| Robert W. Baird | Analyst unavailable | $331 | $328.2 | -21.4% | Apr 23, 2026 |
| Jefferies | David Windley | $391 | $323.05 | -7.1% | Apr 20, 2026 |
| Mizuho Securities | Ann Hynes | $350 | $282.68 | -16.9% | Mar 10, 2026 |
| RBC Capital | Analyst unavailable | $358 | $341.83 | -15.0% | Feb 3, 2026 |
| Truist Financial | Analyst unavailable | $390 | $341.28 | -7.4% | Feb 2, 2026 |
| Piper Sandler | Analyst unavailable | $409 | $340.68 | -2.9% | Feb 2, 2026 |
| Bernstein | Analyst unavailable | $409 | $345.74 | -2.9% | Feb 1, 2026 |
| Wells Fargo | Analyst unavailable | $391 | $346.98 | -7.1% | Jan 30, 2026 |
| Barclays | Analyst unavailable | $393 | $346.98 | -6.7% | Jan 30, 2026 |
| UBS | Analyst unavailable | $400 | $345.27 | -5.0% | Jan 29, 2026 |
| Deutsche Bank | Analyst unavailable | $332 | $345.22 | -21.2% | Jan 29, 2026 |
| Guggenheim | Jason Cassorla | $396 | $341.85 | -6.0% | Jan 29, 2026 |
| Guggenheim | Jason Cassorla | $414 | $369.88 | -1.7% | Jan 22, 2026 |
| Mizuho Securities | Ann Hynes | $413 | $374.77 | -1.9% | Jan 9, 2026 |
| Wolfe Research | Justin Lake | $425 | $366.69 | +0.9% | Jan 8, 2026 |
| Wells Fargo | Analyst unavailable | $424 | $371.37 | +0.7% | Jan 7, 2026 |
| Bernstein | Analyst unavailable | $431 | $368.52 | +2.4% | Jan 6, 2026 |
| Barclays | Andrew Mok | $404 | $354.25 | -4.1% | Jan 5, 2026 |
| Deutsche Bank | George Hill | $320 | $344.6 | -24.0% | Dec 19, 2025 |
| Morgan Stanley | Analyst unavailable | $352 | $345.96 | -16.4% | Dec 18, 2025 |
| Mizuho Securities | Analyst unavailable | $400 | $313.19 | -5.0% | Nov 3, 2025 |
| Barclays | Analyst unavailable | $385 | $340.76 | -8.6% | Oct 22, 2025 |
| Bernstein | Analyst unavailable | $420 | $348.48 | -0.3% | Oct 21, 2025 |
| Truist Financial | Analyst unavailable | $400 | $348.16 | -5.0% | Oct 14, 2025 |
| Morgan Stanley | Erin Wright | $359 | $349.16 | -14.7% | Oct 14, 2025 |
| Goldman Sachs | Analyst unavailable | $343 | $351.42 | -18.5% | Oct 14, 2025 |
| Mizuho Securities | Analyst unavailable | $420 | $362.34 | -0.3% | Oct 9, 2025 |
| Barclays | Analyst unavailable | $395 | $362.34 | -6.2% | Oct 9, 2025 |
| Guggenheim | Analyst unavailable | $398 | $357.49 | -5.5% | Oct 8, 2025 |
| Wells Fargo | Stephen Baxter | $412 | $349.94 | -2.2% | Oct 7, 2025 |
| Truist Financial | David MacDonald | $500 | $389.61 | +18.7% | Jun 9, 2025 |
| Argus Research | Analyst unavailable | $465 | $421.68 | +10.4% | Apr 25, 2025 |
| Jefferies | David Windley | $529 | $430.77 | +25.6% | Oct 21, 2024 |
| Leerink Partners | Whit Mayo | $515 | $430.77 | +22.3% | Oct 21, 2024 |
| Raymond James | Sarah James | $485 | $432.53 | +15.2% | Oct 18, 2024 |
| RBC Capital | Ben Hendrix | $478 | $444.35 | +13.5% | Oct 18, 2024 |
| Truist Financial | David MacDonald | $520 | $444.35 | +23.5% | Oct 18, 2024 |
| Robert W. Baird | Michael Ha | $625 | $483.87 | +48.4% | Oct 16, 2024 |
| RBC Capital | Ben Hendrix | $585 | $502.06 | +38.9% | Jul 18, 2024 |
| Truist Financial | David MacDonald | $620 | $535.54 | +47.2% | Jul 15, 2024 |
| Morgan Stanley | Erin Wright | $643 | $534.42 | +52.7% | Jun 24, 2024 |
| Robert W. Baird | Michael Ha | $649 | $505.52 | +54.1% | May 29, 2024 |
| RBC Capital | Ben Hendrix | $575 | $525.19 | +36.5% | Apr 19, 2024 |
| UBS | AJ Rice | $605 | $525.19 | +43.7% | Apr 19, 2024 |
| Wells Fargo | Stephen Baxter | $600 | $525.19 | +42.5% | Apr 19, 2024 |
| Jefferies | David Windley | $604 | $525.19 | +43.4% | Apr 19, 2024 |
| Barclays | Andrew Mok | $621 | $525.19 | +47.5% | Apr 19, 2024 |
| Mizuho Securities | Analyst unavailable | $575 | $521.88 | +36.5% | Nov 10, 2022 |
| Loop Capital Markets | Joseph France | $550 | $454.76 | +30.6% | Jun 16, 2022 |
| Wells Fargo | Stephen Baxter | $580 | $501.53 | +37.7% | May 25, 2022 |
| BMO Capital | Analyst unavailable | $625 | $495.61 | +48.4% | Apr 25, 2022 |
| Deutsche Bank | Analyst unavailable | $574 | $510.4 | +36.3% | Apr 22, 2022 |
| Morgan Stanley | Analyst unavailable | $607 | $528.45 | +44.1% | Apr 21, 2022 |
| Goldman Sachs | Analyst unavailable | $605 | $529.84 | +43.7% | Apr 21, 2022 |
| Leerink Partners | Analyst unavailable | $555 | $529.84 | +31.8% | Apr 21, 2022 |
| Credit Suisse | Jonathan Yong | $584 | $522.87 | +38.7% | Apr 21, 2022 |
| RBC Capital | Ben Hendrix | $544 | $522.87 | +29.2% | Apr 21, 2022 |
| Evercore ISI | Michael Newshel | $335 | $529.84 | -20.4% | Apr 20, 2022 |
| Mizuho Securities | Ann Hynes | $510 | $529.84 | +21.1% | Apr 20, 2022 |
| Jefferies | David Windley | $625 | $529.84 | +48.4% | Apr 20, 2022 |
| Truist Financial | David MacDonald | $590 | $510.64 | +40.1% | Apr 11, 2022 |
| UBS | Kevin Caliendo | $541 | $489.34 | +28.5% | Apr 4, 2022 |
| J.P. Morgan | Lisa Gill | $500 | $434.61 | +18.7% | Jan 27, 2022 |
| BMO Capital | Matthew Borsch | $510 | $434.61 | +21.1% | Jan 27, 2022 |
| RBC Capital | Ben Hendrix | $452 | $434.61 | +7.3% | Jan 27, 2022 |
| Seaport Global | Joseph France | $480 | $427.24 | +14.0% | Jan 26, 2022 |
| Evercore ISI | Michael Newshel | $335 | $427.24 | -20.4% | Jan 26, 2022 |
| Bernstein | Lance Wilkes | $574 | $452.46 | +36.3% | Jan 11, 2022 |
| Wells Fargo | Steve Baxter | $523 | $438.22 | +24.2% | Jan 6, 2022 |
| Goldman Sachs | Nathan Rich | $517 | $432.72 | +22.8% | Dec 14, 2021 |
| Wolfe Research | Justin Lake | $433 | $403.96 | +2.8% | Nov 30, 2021 |
| Credit Suisse | A.J. Rice | $486 | $428 | +15.4% | Oct 21, 2021 |
| Barclays | Steven Valiquette | $485 | $428 | +15.2% | Oct 21, 2021 |
| Bank of America Securities | Kevin Fischbeck | $465 | $428 | +10.4% | Oct 21, 2021 |
| Cantor Fitzgerald | Steven Halper | $470 | $421.68 | +11.6% | Oct 20, 2021 |
Track every rating change on ELV the moment it posts. Free to start.
Start freeGet the ELV recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.